Sign inJoin waitlistJoin the waitlist

Haitham Abdelhakim

Assistant Professor, Hematologic Malignancies and Cellular Therapeutics · University of Kansas School of Medicine

Credentials: · · · · ·

History

University of Kansas School of Medicine
Present

Hematology and Medical Oncology
University of Kansas
2014–2017
Mayo Clinic
Internal Medicine
University of Kansas
2011–2014
Benha University Faculty of Medicine
2007–2011

Research

IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver
Journal of Clinical Investigation · 2013 · 79 citations
WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1
Journal of Extracellular Vesicles · 2021 · 69 citations
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients
Transplantation and Cellular Therapy · 2021 · 47 citations

Joseph McGuirk
24 papers
Sunil Abhyankar
17 papers
Anurag Singh
15 papers
Muhammad Mushtaq
15 papers · 1 as a fellow
LS
Leyla Shune
12 papers
Moazzam Shahzad
12 papers · 4 as a fellow
NA
Nausheen Ahmed
12 papers
Rajat Bansal
9 papers · 1 as a fellow
SC
Sibgha Chaudhary
7 papers · 2 as a resident
Siddhartha Ganguly
7 papers
FL
Forat Lutfi
6 papers
Joe Al-Ramahi
4 papers · 4 as a resident

Clinical trials

Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Site PI · Recruiting · Phase 1
Marker Therapeutics, Inc.
2025–2029
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Site PI · Recruiting · Phase 1
Marker Therapeutics, Inc.
2023–2028